Vericel Corporation (VCEL)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Vericel Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Vericel Corporation (VCEL) has returned -10.66% so far this year and -27.90% over the past 12 months. Looking at the last ten years, VCEL has achieved an annualized return of 18.23%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Feb 4, 1997, VCEL's average daily return is +0.12%, while the average monthly return is +2.10%. At this rate, your investment would double in approximately 2.8 years.

Historically, 46% of months were positive and 54% were negative. The best month was Mar 2016 with a return of +190.1%, while the worst month was Oct 1999 at -66.7%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 7 months.

On a daily basis, VCEL closed higher 42% of trading days. The best single day was Nov 30, 1999 with a return of +106.2%, while the worst single day was Aug 13, 2013 at -43.4%.

Vericel Corporation has an annualized alpha of 27.04%, beta of 0.78, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since February 05, 1997.

• This stock participated in 161.83% of S&P 500 Index downside but only 89.08% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

VCEL ranks 15 for risk / return — in the bottom 15% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Vericel Corporation (VCEL) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Vericel Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Vericel Corporation was 99.88%, occurring on Nov 17, 2015. The portfolio has not yet recovered.

The current Vericel Corporation drawdown is 97.72%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Vericel Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Vericel Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.